Erythromelalgia is a characteristic thrombotic complication in patients with the myeloproliferative disorders, essential thrombocythemia and polycythemia vera. In this minireview, which is based on more than 20 years of clinical observations and intervention studies, the clinical manifestations, treatment, and pathogenesis of erythromelalgia are discussed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1055/s-2007-996109 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!